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Summary
Signaling by G protein-coupled receptors coupled to
Gi assists in triggering lymphocyte movement into
and out of lymph nodes. Here, we show that modulat-
ing the signaling output from these receptors dramat-
ically alters B cell trafficking. Intravital microscopy of
adoptively transferred B cells from wild-type and
Rgs1−/− mice revealed that Rgs1−/− B cells stick better
to lymph node high endothelial venules, home better
to lymph nodes, and move more rapidly within lymph
node follicles than do wild-type B cells. In contrast, B
cells from Gnai2−/− mice enter lymph nodes poorly
and move more slowly than do wild-type B cells. The
Gnai2−/− mice often lack multiple peripheral lymph
nodes, and their B cells respond poorly to chemo-
kines, indicating that Gi1 and Gi3 poorly compen-
sate for the loss of Gi2. These results demonstrate
opposing roles for Rgs1 and Gnai2 in B cell traffick-
ing into and within lymph nodes.
Introduction
Blood borne B lymphocytes use L-selectin (CD62L) and
its counter-receptor, peripheral node addressin, to
tether and roll in the high endothelial venules (HEVs) of
peripheral lymph nodes (Arbones et al., 1994; Berg et
al., 1991; Gallatin et al., 1983; Lasky et al., 1992;
Streeter et al., 1988). Once they are tethered, B lympho-
cytes encounter one of the chemokines CCL19, CCL21,
or CXCL12 on the luminal side of the HEV (Okada et al.,
2002). Chemokine receptor activation triggers a confor-
mation change in lymphocyte function associated-anti-
gen (LFA)-1 and B lymphocyte arrest. LFA-1 triggering
on rolling lymphocytes is sensitive to pertussis toxin,
implicating members of the Gi subfamily of heterotri-
meric G proteins in the signaling pathway (Bargatze
and Butcher, 1993). Gi signaling is also implicated in
the subsequent diapedesis step across the HEV (Cyster
and Goodnow, 1995; Warnock et al., 1998). Once B
cells enter the lymph node, they traverse the T cell area
to access the B cell follicles, a Gi-dependent process
mediated by CXCL13 signaling (Ansel et al., 2000). Vi-
sualization of transferred B cells revealed that, within
the B cell follicle, they move in random directions with*Correspondence: jkehrl@niaid.nih.govan average velocity of 6.4 m/min (Miller et al., 2002).
Whether Gi signaling has a role in B cell movement
within the follicle or in their exit from the follicle is un-
known. If B cells fail to encounter antigen, they exit the
lymph node through the efferent lymph vessels. A series
of elegant studies have implicated another Gi-linked re-
ceptor, type 1 sphingosine-1-phosphate receptor (S1P1),
in the control of B and T lymphocyte egress (Allende
et al., 2004; Dorsam et al., 2003; Mandala et al., 2002;
Matloubian et al., 2004). However, the precise role of
S1P1 signaling in directing lymphocyte egress is un-
known (Cinamon et al., 2004).
Chemokine receptors and S1P1 transduce intracellu-
lar signals by activating the exchange of GTP for GDP
of the α subunit of Gi. This causes the dissociation of
Gi, freeing the βγ heterodimer to trigger intracellular sig-
naling pathways that lead to directed cell migration
(Arai et al., 1997; Neptune and Bourne, 1997; Neptune
et al., 1999). Murine lymphocytes predominantly ex-
press two members of the Gnai subfamily, Gnai2 and
Gnai3 (Su et al., 2002). Mice deficient in Gnai3 are with-
out a reported phenotype (Wettschureck et al., 2004);
however, mice lacking Gnai2 develop a TH1-mediated
inflammatory colitis reminiscent of human ulcerative
colitis whose penetrance depends upon the genetic
background of the mice (Hornquist et al., 1997; Ru-
dolph et al., 1995). Gnai2−/− CD4+ T cells exhibit aug-
mented responses to T cell receptor (TCR) signaling,
with enhanced intracellular calcium release and cyto-
kine production (Hornquist et al., 1997; Huang, et al.,
2003). In contrast, Gnai3−/− T cells respond normally to
TCR signaling (Huang et al., 2003). Besides the T cell
defects, B cell development is impaired in Gnai2−/−
mice (mixed 129Sv/C57 background), with a relative
depletion of marginal zone B cells in the spleen and
B1 B cells in the peritoneum (Dalwadi et al., 2003). An
increase in mature thymocytes in the thymus and a
paucity of Peyer’s patches has also been noted in these
mice (Rudolph et al., 1995; Ohman et al., 2002).
Following receptor activation of Gi, the duration that
βγ heterodimers remain available to signal depends in
part upon the intrinsic GTPase activity of the Gαi sub-
units (Hepler and Gilman, 1992; Neer, 1995). Once Gαi
hydrolyzes GTP, the GDP bound Gαi effectively com-
petes for the released βγ heterodimers, terminating sig-
naling. Also controlling the duration that Gαi subunits
remain GTP bound are members of the Regulator of G
protein Signaling (RGS) protein family, which dramati-
cally increase the intrinsic Gαi GTPase activity, a prop-
erty that defines them as GTPase activating proteins
(GAPs) (Kehrl, 1998). Murine lymphocytes express a
number of RGS proteins (Su et al., 2002; Moratz et al.,
2004a), and mice with targeted disruptions of Rgs1 and
Rgs2 have immune phenotypes. Rgs2−/− mice have T
cells that proliferate poorly and make lower levels of
interleukin-2 (Oliveira-Dos-Santos et al., 2000). Rgs1−/−
mice possess B cells that respond aberrantly to che-
mokines. Immunization of these mice leads to exagger-
ated germinal center formation, partial disruption of the
normal architectures of the spleen and Peyer’s patches,
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tcells (Moratz et al., 2004b).
tThe data implicating Gi usage by chemokine recep-
ators and S1P1 have relied upon the use of pertussis
atoxin, which inhibits Gi GDP-GTP exchange. We have
vtaken a more subtle approach and have used geneti-
wcally manipulated mice, which possess either impaired
por enhanced Gαi signaling compared to B cells from
dwild-type mice, as a source of B lymphocytes. The
mGnai2−/− B cells have less Gαi available to couple to
athese receptors, while Rgs1−/− B cells lack a potent
cnegative regulator of Gαi. Our experiments have dem-
aonstrated that Rgs1 and Gnai2 impact the frequency at
pwhich B cells enter into peripheral lymph nodes and the
amotility of B cells within the follicles.
a
cResults
e
bMore Rgs1−/− splenic B cells migrate to the chemokines
eCXCL12 and CXCL13 in standard filter-based transwell
wassays than do wild-type B cells (Moratz et al., 2004b).
tWhen the chemokine gradient is disrupted, the migra-
7tion of the wild-type and Rgs1−/− B cells decreased to
inear background levels, confirming that the difference
tnoted between them was not due to chemokinesis (Fig-
ure 1A and data not shown). The Rgs1−/− B cells also
texhibited a greater sensitivity to pertussis toxin than
kdid wild-type B cells, suggesting that RGS1 may par-
otially protect Gi from pertussis toxin labeling (Figure m1B). Next, we purified wild-type and Rgs1−/− B cells
ffrom mouse spleens, labeled them with CMFDA and
CMTMR, respectively, and injected equal numbers in-
mtravenously into a wild-type recipient. Two and 24 hr
elater, we checked the distribution of the transferred
Pcells in the blood, spleen, and lymph nodes by flow
v
cytometry. We found similar number of wild-type and
n
Rgs1−/− B cells in the lymphocyte gate from spleen; an
enrichment of Rgs1−/− B cells relative to the control
c
cells in lymph nodes, both on a percentage basis and i
in absolute cell numbers; and a decrease of Rgs1−/− B t
cells in the peripheral blood (Figures 1C and 1D and t
data not shown). We also verified by flow cytometry m
that chemokine receptors, L-selectin, and integrins b
were expressed on the wild-type and Rgs1−/− B cells h
at similar levels (Table S1; see the Supplemental Data s
available with this article online). f
Next, we directly imaged the cells in the inguinal s
lymph node by intravital multiphoton microscopy. We a
acquired three-dimensional image stacks sequentially 1
every 15 s and tracked individual cells in a volume pro- R
jection. A representative image from the multiphoton t
microscopy shows the presence of more Rgs1−/− B s
cells (red) than wild-type B cells (green) in the lymph t
node (Figure 1E). Time-lapse videos compressed along R
the z axis revealed that both the wild-type and Rgs1−/− c
B cells moved within the lymph node. In contrast to T c
cells, which move in a series of repetitive lunges, the B m
cells moved more uniformly. The majority of the cells t
displayed a polarized cell morphology and amoeboid- o
like cell movements with active membrane projections. i
An examination of individual tracks from wild-type and u
Rgs1−/− B cells at 24 hr after transfer revealed that the s
sRgs1−/− B cells better outlined the presumed B cell folli-les, while at 36 hr after transfer, we no longer noted
he difference (data not shown). The B cells in the cen-
er of lymph node follicle moved freely, while those
long the edge appeared physically constrained, as if
barrier prevented their egress from the follicle. The
elocity of Rgs1−/− B cell appeared to exceed that of
ild-type B cells (see Movie S1, available with the Sup-
lemental Data). When we analyzed the tracks of ran-
omly chosen wild-type and Rgs1−/− B cells from one
ovie, we found that the wild-type cells moved with an
verage speed of 6.12 m/min, while the Rgs1−/− B
ells moved with an average speed of 7.49 m/min,
lthough the trafficking patterns of individual cells ap-
eared similar (Figures 1F and S1). In addition, an ex-
mination of the cell velocity distribution plot revealed
n enrichment of rapidly moving cells in the Rgs1−/− B
ell population, which accounted for much of the differ-
nce in the average velocities. To confirm the difference
etween the wild-type and Rgs1−/− B cells, we analyzed
ight separate movies. The wild-type B cells moved
ith an average velocity of 5.92 ± 0.27 m/min, and
he Rgs1−/− B cells moved with an average velocity of
.31 ± 0.3 m/min (Figure 1G). The trafficking and motil-
ty differences were independent of which dye we used
o label the cells (data not shown).
A possible reason for the difference in cell velocity is
he enhanced sensitivity of Rgs1−/− B cells to chemo-
ines. To test that possibility, we measured the speed
f individual wild-type and Rgs1−/− B cells in collagen
atrices. Time-lapse recordings revealed a small dif-
erence in their average speeds, 3.1 m/min and 4.1
m/min, respectively; however, adding CXCL12 to the
edia overlying the collagen matrix widened the differ-
nce to 4.2 and 8.2 m/min, respectively (Figure 1H).
ertussis toxin treatment inhibited the increase in cell
elocity of both the wild-type and Rgs1−/− B cells (data
ot shown).
To test whether the enhanced entrance of Rgs1−/− B
ells into lymph nodes was secondary to more efficient
nteractions with HEVs, we used intravital microscopy
o analyze the behavior of fluorescently labeled wild-
ype and Rgs1−/− B cells in the inguinal lymph node
icrocirculation of wild-type mice. The hierarchical
ranching of venules within peripheral lymph nodes
as five distinct venular orders, with orders 3–5 corre-
ponding to paracortical HEV (von Andrian, 1996). We
ocused on these higher-order venules and collected
even consecutive 10 min movies spanning 32–120 min
fter transfer. Figure 2A shows a representative image
10 min after transfer that reveals a predominance of
gs1−/− B cells (red) versus wild-type B cells (green) in
he peripheral venules (Movie S2). A 4× electronic zoom
hows the outlined region at 32, 72, 84, and 98 min after
ransfer. At each time point, the number of adherent
gs1−/− B cells exceeded the number of wild-type B
ells. When we quantified the number of firmly adherent
ells in each of the movies, approximately twice as
any Rgs1−/− B cells had firmly adhered compared to
he wild-type cells (Figure 2B). Finally, in another series
f experiments, we determined the percentage of roll-
ng cells and their sticking efficiency in 12 different ven-
les from 6 adoptively transferred mice. Figure 2C
hows that the rolling fraction of lymphocytes did not
ignificantly differ between Rgs1−/− B cells and those
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345Figure 1. Rgs1−/− B Cells Home Efficiently to
Lymph Nodes and Exhibit Enhanced Motility
Compared to Wild-Type B Cells
(A) Checkerboard analysis. Splenic B cells
were resuspended in medium containing
various concentrations of CXCL12 just be-
fore transfer to the upper chamber (*p < 0.01
versus medium only).
(B) Effect of pertussis toxin (Ptx) on chemo-
taxis of purified B cells from spleen or lymph
node. The cells were treated with 1 or 10 ng/
ml Ptx for 2 hr at 37°C. The percentage of
migration is shown as mean ± SD of tripli-
cate samples, which are representative of
one of three experiments performed (*p <
0.01 versus CXCL12-treated group).
(C and D) Homing assay. Twenty million
CMFDA-labeled Rgs1−/− B cells and the same
number of CMTMR-labeled wild-type (wt) B
cells were intravenously transferred to recip-
ient mice (n = 3). Two hours after transfer,
cells from blood (first panel), spleen (second
panel), inguinal lymph nodes (third panel),
and popliteal lymph nodes (fourth panel) of
recipient mice were analyzed by using a flow
cytometer. Shown in (D) is the actual number
of transferred B cells found in blood (per 10
l), spleen (×104 cells), inguinal lymph nodes
(×102 cells), and popliteal lymph nodes (×10
cells), (*p < 0.05 versus wt; wt, white bars;
Rgs1−/− B cells, black bars).
(E) Intravital imaging. Twenty-four hours after
cell transfer, inguinal lymph nodes were im-
aged intravitally by using a multiphoton
microscope (CMTMR-labeled Rgs1−/− B cells
and CMFDA-labeled wt B cells). A represen-
tative image is shown (original magnification,
200×; electronically zoomed, 4×).
(F) B cell velocity profile. The data show fre-
quency histograms of three-dimensional ve-
locities (n = 740 wt B cell spots and 1248
Rgs1−/− B cell spots). The average speeds
are indicated with arrows.
(G) Mean velocity of wt and Rgs1−/− B cells.
Speed was calculated from eight indepen-
dent movies by spot analysis with Imaris
software v4.1.1. The average speeds (5.92 ±
0.27 m/min for wt and 7.31 ± 0.3 m/min
for Rgs1−/− B cells) are indicated with bars
(*p < 0.01 versus wt).
(H) Velocity in collagen matrices. Wild-type and Rgs1−/− splenic B cells were embedded in collagen matrix and imaged by time-lapse phase-
contrast microscopy. Randomly chosen individual B cells were manually tracked. Results are from 15 wt and 15 Rgs1−/− B cells in 3 separate
experiments. Cell tracking began 15 min after the addition of CXCL12 (100 ng/ml).
Standard deviation (SD) and p values were calculated with a Student’s t test.from wild-type mice. However, the sticking fraction of
Rgs1−/− B cells exceeded that of wild-type by 275%, a
result consistent with the 2-fold increase in Rgs1−/− B
cell homing.
For several reasons, the duration that Rgs1−/− B cells
remain within the lymph node might be different than
that of wild-type B cells. First, the greater motility of
Rgs1−/− B cells may impact their retention rate. Second,
Rgs1 also negatively regulates S1P1 signaling, and its
absence could enhance the strength of an egress sig-
nal. A previous study had shown that S1P1 signaling is
sensitive to RGS1 (Cho et al., 2003). Third, the lack of
Rgs1 may prevent the desensitization to a localizing
chemokine, thereby preventing egress. To compare
wild-type and Rgs1−/− B cell retention in peripherallymph nodes, we transferred differentially labeled wild-
type and Rgs1−/− B cells to wild-type recipients, and 2
(Figure 3A) or 24 hr (Figure 3B) later, we blocked further
lymphocyte ingress by the intravenous injection of an
L-selectin-specific antibody. We compared the number
of wild-type and Rgs1−/− B cells in lymph nodes 24 hr
after antibody injection. We also plotted the data as the
ratio between the recovered cells in the presence or
absence of antibody. The treatment with anti-L-selectin
antibody significantly reduced lymph node sizes and
the recovery of lymphocytes from them. It also in-
creased the number of transferred B cells found in the
peripheral blood. However, the ratios between PBS-
and antibody-treated wild-type and Rgs1−/− B cells in
the blood and lymph nodes were similar. Since we com-
Immunity
346Figure 2. Rgs1−/− B Cells Showed Enhanced
Adherence to High Endothelial Venules Com-
pared to Wild-Type B Cells
(A) Images of wt and Rgs1−/− B cells in the
microcirculation of recipient mice. Ten mil-
lion labeled cells of each population were in-
jected intravenously into recipient mice and
visualized by epifluorescence illumination.
Images were recorded every 5 s for 10 min,
and seven consecutive movies were col-
lected from 32 min to 120 min. Representa-
tive images (original magnification, ×200)
collected 110 min after cell transfer and four
zoomed images (4×) of the outlined region
collected 32, 72, 84, and 98 min after cell
transfer are shown.
(B) Time-response graph for wt and Rgs1−/−
B cell adherence in HEVs. The number of
firmly adherent cells in venules for >5 min
was determined for each image. Results are
expressed as the number of adherent cells
per image. The number of input cells was
confirmed by flow cytometry and by count-
ing the total flux passing through the venules
5 min after cell transfer.
(C) Rolling and sticking fractions of wt (white
bars) and Rgs1−/− B cells (black bars) in
HEVs. Images were recorded every 1 s. The
total flux of cells was determined by count-
ing all cells that passed through each venule.
The rolling fraction was calculated by divid-
ing the flux of rolling cells by the total flux.
The sticking fraction was defined as the percentage of rolling cells that became firmly adherent for >30 s. Data are mean ± SD (12 venules,
6 mice, *p < 0.01).
Standard deviation (SD) and p values were calculated with a Student’s t test.pared different mice, some variation in the experimental G
cresults are expected and temper the conclusion drawn,
but we can conclude that there is not a major difference n
min the lymph node transit times. We verified that the
anti-L-selectin antibody completely blocked the en- m
etrance of transferred Rgs1−/− B cells and wild-type B
cells into lymph nodes (data not shown). n
cWhile Rgs1−/− B cells exhibit a heightened sensitivity
to chemokine stimulation, B cells derived from mice n
mwith defective Gi activation would be expected to have
the opposite phenotype. Therefore, we examined B o
acells from Gnai2−/− mice. We first compared the ability
of Gnai2−/− B cells to migrate to chemokines in stan- l
hdard filter-based assays versus wild-type B cells. The
Gnai2−/− cells responded poorly to CXCL12, CXCL13, t
wand CCL19, with only a 2- to 3-fold increase over the
spontaneous migration, although the dose response s
rcurves appeared similar to those of wild-type cells (Fig-
ures 4A–4C). The Gnai2−/− B cells also exhibited a sig- i
cnificant refractoriness to pertussis toxin (Figure 4D).
Treatment failed to significantly impair either the spon- s
vtaneous or chemokine-induced migration of Gnai2−/− B
cells. This result was surprising, as we had assumed a
lthat Gαi3 would partially compensate for the lack of
Gαi2. We also examined the activation of ERK following T
pchemokine receptor stimulation or following exposure
to anti-IgM (Figure S2). Both CXCL12 and CCL19 elic- t
Gited a suboptimal ERK response in the Gnai2−/− B cells,
while anti-IgM treatment induced a modestly higher
GERK activation in these cells.
An examination of the lymphoid compartments in vnai2−/− mice strongly suggested problems in lympho-
yte trafficking and lymph node development. While the
umbers of lymphocytes in the spleens of Gnai2−/−
ice were similar to those of wild-type, we found a
arked increase in Gnai2−/− lymphocytes in the periph-
ral blood compared to wild-type, and in those lymph
odes present, a marked reduction in Gnai2−/− lympho-
ytes (Figure 5A). Figure 5B shows the lack of an ingui-
al lymph node in a Gnai2−/− mouse. Examination of 6
ice on a C57BL/6 background revealed the presence
f only 2 of the expected 12 inguinal lymph nodes and
n absence of popliteal lymph nodes. Mesenteric
ymph nodes were present in five of six mice, but none
ad visible Peyer’s patches (data not shown). To test
he trafficking and motility of Gnai2−/− B cells in vivo,
e purified wild-type and Gnai2−/− B cells from mouse
pleens, labeled them with CMFDA and CMTMR,
espectively, and injected equal numbers intravenously
nto a wild-type recipient. Two and 24 hr later, we
hecked the distribution of the transferred cells in the
pleen and lymph nodes by flow cytometry, which re-
ealed an increase of the Gnai2−/− B cells in the blood
nd spleen, but a decrease in the inguinal and popliteal
ymph nodes (Figures 5C and 5D and data not shown).
o ascertain that the Gnai2−/− B cells lacked Gαi2 ex-
ression, we analyzed cell lysates prepared from wild-
ype and Gnai2−/− B cells. As expected we found, no
αi2 and an increase in Gαi3 in them (Figure 5E).
Despite the reduced lymph node homing of the
nai2−/− B cells, we were able to prepare time-lapse
ideos from multiphoton microscopy of inguinal lymph
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347Figure 3. The Rgs1−/− and Wild-Type B Cells
Leave Inguinal Lymph Nodes at Similar
Rates
(A and B) Ten million CMTMR-labeled Rgs1−/−
B cells and the same number of CMFDA-
labeled wt B cells were intravenously trans-
ferred into recipient mice (n = 3). Anti-L-
selectin antibody (100 g/mouse, black
bars) was injected intravenously (A) 2 hr or
(B) 24 hr after cell transfer. Control mice were
injected with PBS (white bars). Cells were
isolated from blood, inguinal, and popliteal
lymph nodes and analyzed by using a flow
cytometer 24 hr after antibody injection. The
actual numbers of transferred B cells in or-
gans (top and middle panels) and the ratios
between the antibody-treated group and the
PBS-treated control group are shown (bot-
tom panels) (*p < 0.01 versus control). Stan-
dard deviation (SD) and p values were calcu-
lated with a Student’s t test.Figure 4. Defective Response of Gnai2−/− B
Cells to Chemokines
(A–C) Chemotaxis assays. B cells purified
from wild-type (wt, white bars) and Gnai2−/−
(black bars) mice were subjected to a 2 hr
chemotaxis in response to (A) CXCL12, (B)
CXCL13, and (C) CCL19. Results are from
the mean of duplicate samples and are re-
presentative of one of three experiments
performed.
(D) Effect of pertussis toxin (Ptx). B cells
were treated with 100 ng/ml Ptx for 2 hr,
washed, and subjected to a chemotaxis as-
say for 2 hr. The percentages of B cells re-
sponding to 30 ng/ml CXCL12, 100 ng/ml
CXCL13, and 10 ng/ml CCL19 are shown as
a mean of the duplicate samples, which are
representative of one of three experiments.
Immunity
348Figure 5. Defective Lymph Node Development in Gnai2−/− Mice and Impaired Homing of Gnai2−/− B Cells to Lymph Nodes
(A) Cell distribution. Total lymphocytes were isolated from blood (103/l), spleen (×107), inguinal lymph nodes (×106), and popliteal lymph
nodes (×106) from wild-type (wt) and Gnai2−/− mice. Data show the mean ± SD of six mice (*p < 0.01 versus wt). ND; not detected.
(B) Representative photograph of an inguinal lymph node from wild-type (left, arrow) and Gnai2−/− mice (right).
(C and D) B cell homing. Seven million CMTMR-labeled Gnai2−/− B cells and the same number of CMFDA-labeled wt B cells were intravenously
transferred into recipient mice (n = 3). Two hours after cell transfer, single cells were isolated from blood (first panel), spleen (second panel),
inguinal lymph nodes (third panel), and popliteal lymph nodes (fourth panel) of recipient mice and analyzed by using a flow cytometer. The
numbers show the percentage of total lymphocyte-sized cells. Shown in (D) is the actual number of transferred B cells in blood (per 10 l),
spleen (×104), inguinal lymph nodes (×10), and popliteal lymph nodes (×10) of the recipient mice (n = 3, *p < 0.01 versus wt).
(E) G protein expression. Protein lysates were prepared from purified B cells, and the amounts of Gαi1, Gαi2, and Gαi3 were detected with
specific antibodies by immunoblotting.
Standard deviation (SD) and p values were calculated with a Student’s t test.nodes of recipient mice. As expected, they revealed c
mfewer Gnai2−/− B cells in the lymph node than wild-type
cells (Figure 6A, left panel; Movie S3). Examination of v
Gthe individual tracks showed that the Gnai2−/− B cells
moved more slowly, often oscillating rather than em- c
tploying the typical ameboid movements we had ob-
served with the Rgs1−/− and wild-type B cells (Figure
c6A, middle and right panels). When we analyzed tracks
of randomly chosen wild-type and Gnai2−/− B cells from i
tone movie, we found that the wild-type cells moved
more quickly, and we noted a leftward shift of the veloc- t
oity distribution of the Gnai2−/− B cells compared to wild-
type B cells (Figure 6B and Figure S1). To confirm the o
ldifference between the wild-type and Gnai2−/− B cells,
we analyzed four separate movies. The wild-type B 7ells moved with an average velocity of 5.78 ± 0.28 m/
in, and the Gnai2−/− B cells moved with an average
elocity of 4.59 ± 0.43 m/min (Figure 6C). Thus,
nai2−/− B cells enter lymph nodes poorly, and those
ells that do enter move less vigorously than do wild-
ype B cells.
The transwell assay data suggested that Gnai2−/− B
ells could respond to chemokines, albeit weakly even
n the presence of pertussis toxin. To examine whether
hat translated to an observable difference in vivo, we
ransferred wild-type B cells or Gnai2−/− B cells, each
f which had been treated with pertussis toxin ex vivo
r not. We measured their entrance into peripheral
ymph nodes or spleen by using flow cytometry (Figures
A–7D). As expected, pertussis toxin treatment com-
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349Figure 6. Defective Movement of Gnai2−/− B
Cells in the Follicle.
Seven million CMFDA-labeled Gnai2−/− B
cells and the same number of CMTMR-
labeled wild-type (wt) B cells were intrave-
nously transferred into recipient mice (n = 3).
Twenty-four hr after cell transfer, inguinal
lymph nodes were imaged intravitally by
using a multiphoton microscope equipped
with a 20× lens. Standard deviation (SD) and
p values were calculated with a Student’s t
test.
(A) A representative image of an inguinal
lymph node is shown (left, 4× zoom). Repre-
sentative tracts of CMTMR-labeled wt B
cells (middle, 8× zoom) and CMFDA-
labeled Gnai2−/− B cells (right, 8× zoom) are
shown. Tracks were obtained over 10 min
of imaging.
(B) B cell velocity profile. Data show fre-
quency histograms of three-dimensional ve-
locities (n = 670 wt B cell spots and 248
Gnai2−/− B cell spots). The average speeds
are indicated with arrows.
(C) Mean velocity of wt and Gnai2−/− B cells.
Analysis of four independent movies is
shown. The average speeds (5.78 ± 0.28 m/
min for wt B and 4.59 ± 0.43 m/min for
Gai2−/− B cells) are indicated with bars (*p <
0.01 versus wt).pletely inhibited the entrance of wild-type B cells into
lymph nodes; however, it had a very modest effect on
the relatively poor entrance of Gnai2−/− B cells. This
suggests that Gnai2−/− B cells have developed a com-
pensatory mechanism to enter into lymph nodes that
doesn’t depend on the use of pertussis toxin-sensitive
G proteins.
Finally, our studies of Rgs1−/− and Gnai2−/− B cell mo-
tility in the lymph node follicles argues for a role for
GPCR signaling in the regulation of their movement. To
provide further evidence for that possibility, we at-
tempted to assess the effect of inhibiting Gi signaling
on the motility of wild-type and Rgs1−/− B cells in lymph
nodes. Since ex vivo treatment with pertussis toxin in-
hibits entrance into lymph nodes, we transferred la-
beled B cells and 4 hr later administered pertussis toxin
to the recipient (500 ng/mouse). Twenty hours after per-
tussis toxin injection, we acquired time-lapse image
z-stacks of inguinal lymph nodes by intravital multipho-
ton microscopy. The wild-type and the Rgs1−/− B cells
moved sluggishly compared to what we had observed
in the absence of pertussis toxin (see Movie S4). When
we analyzed the tracks of one movie and computed the
average velocities from four separate movies, we found
that the velocity distributions of both the wild-type and
the Rgs1−/− B cells had been shifted leftward and that
the average velocities reduced to 4 and 5.6 m/min,
respectively (Figures 7E and 7F). These represent an
approximate 23% decrease for Rgs1−/− B cells and a
32% decrease in the wild-type B cells compared to the
velocities we measured in the absence of pertussis
toxin. To check the efficacy of pertussis toxin treat-
ment, we preformed transwell assays with spleen and
lymph node B cells from the treated mice; these assays
showed that pertussis toxin blocked the spleen B cellresponses, but only partially inhibited the lymph node
B cell responses (data not shown). This suggests that
a more complete inhibition may more dramatically im-
pact B cell motility. However, several caveats must be
considered when interpreting the pertussis toxin data,
including the possibilities that pertussis toxin has un-
known and unintended effects, that it may inhibit other
GPCRs that affect the behavior of lymphocyte or other
cell types, and that it may raise cAMP levels in the cells,
thereby affecting their migration.
Discussion
These results provide a number of insights into B cell
lymph node trafficking and chemokine receptor signal-
ing. First, the expression levels of Rgs1 and Gnai2 im-
pact the entrance of B cells into peripheral lymph
nodes. The absence of Rgs1 enhances the likelihood of
entry, while an absence of Gnai2 inhibits entry. Second,
the lack of Rgs1 facilitates the entrance of B cells into
B cell follicles and their motility in the follicle, while the
lack of Gnai2 has the opposite effect. Third, the lack
of Rgs1 does not dramatically alter the transit time of
unactivated B cells through peripheral lymph nodes.
Fourth, CXCR4, CXCR5, and CCR7 couple predomi-
nantly to Gαi2 in B lymphocytes, and, in its absence,
they may couple to a non-pertussis toxin-sensitive G
protein. Fifth, the lack of Gnai2 severely impairs chemo-
kine receptor signaling, leading to defective chemo-
taxis and likely accounting for the failure of normal pe-
ripheral lymph node development in many Gnai2−/−
mice.
Our data extend previous studies that have shown
that pertussis toxin treatment blocks the entrance of
lymphocytes into lymph nodes (Bargatze and Butcher,
Immunity
350Figure 7. Effect of Ex Vivo and In Vivo Per-
tussis Toxin Treatment on B Cell Homing and
Movement in the Follicle
(A–D) Effect of ex vivo Ptx treatment on
lymph node homing. (A and C) wt B cells
were treated with 100 ng/ml Ptx for 2 hr,
washed two times, and then labeled with
CMFDA. Control wild-type B cells were la-
beled with CMTMR. Ten million of each were
injected intravenously into the recipient mice
(n = 3). Twenty-four hr after cell transfer, cells
were isolated from blood (first panel), spleen
(second panel), inguinal lymph nodes (third
panel), and popliteal lymph nodes (fourth
panel). The percentage of transferred cells
(shown in [A]) was analyzed by using a flow
cytometer, and the actual number of trans-
ferred B cells in the blood (per 10 l), spleen
(×104), inguinal lymph node (×102), and popli-
teal lymph node (×102) is shown in (C) (n = 3,
*p < 0.01 versus Ptx-untreated wt B cells).
ND; not detected. (B and D) Ptx-treated
Gnai2−/− B cells were labeled with CMTMR,
and untreated control Gnai2−/− B cells were
labeled with CMFDA (note dye change and
hence axis change). A similar experiment
was performed to that described above; flow
cytometer results are shown in (B), and the
actual number of transferred B cells is
shown in (D) (*p < 0.01 versus Ptx-untreated
Gnai2−/− B cells).
(E and F) In vivo Ptx inhibits the motility of
wt and Rgs1−/− B cells. Ten million CMTMR-
labeled Rgs1−/− B cells and the same
number of CMFDA-labeled wt B cells were
intravenously transferred into recipient mice
(n = 3). Four hr after cell transfer, 500 ng Ptx
was injected intravenously. Twenty-four hr
after cell transfer, inguinal lymph nodes were
imaged intravitally by using a multiphoton
microscope equipped with a 20× lens. Data
show frequency histograms (shown in [E]) of
three-dimensional velocities (n = 187 wt B cell
spots and 424 Rgs1−/− B cell spots), which
are representative of six images. The average speeds are indicated with arrows. The mean velocity of wt and Rgs1−/− B cells in six independent
movies is shown in (F). The average speeds (4.00 ± 0.10 m/min for wt B cells and 5.60 ± 0.12 m/min for Rgs1−/− B cells) are indicated with
bars (*p < 0.01).
Standard deviation (SD) and p values were calculated with a Student’s t test.1993; Cyster and Goodnow, 1995; Warnock et al., t
l1998). These previous results can now be attributed
largely to the effect of pertussis toxin on Gαi2, not other c
bpertussis toxin-sensitive G proteins. In addition, en-
trance into lymph nodes is controlled not only by ex- t
ipression of the appropriate chemokine receptors, but
also by the strength of the intracellular signals gener- m
eated, which may depend upon the ratio between RGS1
and Gαi2. While we have focused on B cells, T cells m
aare presumably subject to the same regulation. Mouse
CD4+ T cells also express Rgs1 (Moratz et al., 2004b) m
Fas well as other RGS proteins (Moratz et al., 2004a; Su
et al., 2002). In this study, we not only assessed the t
aappearance of cells in lymph nodes, but we also di-
rectly compared the ability of wild-type B and Rgs1−/− t
mB cells to roll and adhere to HEVs. Presumably due to
an enhanced sensitivity to chemokines, Rgs1−/− B cells
fadhere to HEVs and home to lymph nodes more effi-
ciently do wild-type cells. t
rOur results provide an impetus to examine Gα andi2
RGS1 levels in different lymphocyte subsets and to de-ermine how their expression changes as a function of
ymphocyte activation. That antigen stimulation of B
ells strongly increases Rgs1 expression has already
een reported (Moratz et al., 2000, 2004b; Reif and Cys-
er, 2000). It is likely that a B cell activated outside of
mmune tissues, for example in an inflammatory site,
ay have a narrow temporal window in which it can
fficiently enter into a peripheral lymph node. Such a
echanism might serve to localize B cell proliferation
nd differentiation predominantly within the environ-
ent of lymph nodes and the white pulp of the spleen.
urther experiments are needed to formally prove that
he ratio between RGS1 and Gαi2 alters B cell homing
nd trafficking. Experiments analyzing the homing and
rafficking of Rgs1+/−, Gnai2+/−, and Rgs1−/−Gnai2+/−
ice are planned.
The large amount of literature, which supports a role
or chemokines in mediating homing and compartmen-
alization of lymphocytes in lymphoid organs, has been
ecently challenged by a more stochastic view of lym-phocyte motility and trafficking (Wei et al., 2003). Our
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signaling through Gi-coupled receptors like chemokine
receptors affects B lymphocyte motility in lymphoid tis-
sues and that sources of these chemoattractants un-
doubtedly modulate the trafficking of B lymphocytes into
and likely within the follicle. Comparing the Rgs1−/− B
cells, which possess a heightened sensitivity to Gi sig-
naling, to wild-type cells helped reveal some of the con-
sequences of Gi signaling within the lymph node. In ad-
dition, the poor movement of the Gnai2−/− B cells is
consistent with a role for chemokine signaling in con-
trolling B cell movement in the lymph node follicle. In
fact, the velocity of the Gnai2−/− B cells is likely artifac-
tually elevated due to cell shape change and oscillatory
movements that change the center of the cell mass,
and thereby affect the spot analysis (Bousso and Ro-
bey, 2003). Also not generally appreciated is that chem-
okines can alter the velocity of lymphocyte movements
in addition to providing directional clues. Nevertheless,
B cells likely possess an intrinsic motility independent
of input from Gi signaling.
The average B cell velocities that we calculated for
the wild-type B cells were similar to those previously
reported with detached lymph nodes (Miller et al.,
2002). This is despite some difference in experimental
set-up and the methodology chosen to analyze the ve-
locities. The enhanced velocity of the Rgs1−/− B cells
along with their apparent facile entrance into lymph
nodes suggests that Rgs1−/− B cells might transit
through the lymph node more rapidly than do wild-type
B cells. In contrast, if Rgs1 normally functions to de-
sensitize a localizing chemokine receptor, the Rgs1−/−
B cells might be abnormally retained in lymph nodes.
While we did not detect an appreciable difference in
the retention time of unactivated wild-type and Rgs1−/− B
cells, perhaps a more meaningful question is what are
the consequences of B cell activation, which signifi-
cantly increases Rgs1 expression, on B cell trafficking
in the lymph node. Relevant to this point, the analysis
of Rgs1−/− mice revealed a reduction in the size of Pey-
er’s patches following immunization, a result consistent
with a failure to properly retain activated cells (Moratz
et al., 2004b). In preliminary experiments, the treatment
of Rgs1−/− and wild-type mice with zymosan led to an
early increase in the ratio between lymphocytes in pe-
ripheral lymph nodes of Rgs1−/− versus wild-type mice.
However, several days later, the ratio reversed, implying
a failure of the Rgs1−/− lymph nodes to efficiently retain
lymphocytes. We are devising additional experiments
to test the following model. In the absence of B cell
activation, Rgs1 expression remains low, B cells enter
lymph nodes efficiently, B cell motility within the lymph
node is high, and the likelihood of B cell egress trig-
gered by S1P1 signaling is high, thereby facilitating B
lymphocyte recirculation. If a B cell within the lymph
node receives a B cell activation signal, Rgs1 expres-
sion levels rise, the magnitude of Gi signaling falls, B
cell motility declines, and the chance that a B cell
leaves the lymph node by S1P1 signaling declines. At
some point, Rgs1 declines, raising the probability that a
newly generated effector B cell leaves the lymph node.
Superimposed upon the regulation of Rgs1 are alter-
ations in the expression levels of chemokine receptors,
S1P , and perhaps Gα , which also influence B cell1 i2
motility and egress.The poor response of the B cells from the Gnai2−/−
mice to chemokines and the inability of pertussis toxin
to block the residual responses argue that the chemo-
kine receptors CXCR4, CXCR5, and CCR7 on B cells
couple predominantly to Gαi2. The failure of pertussis
toxin to inhibit the residual response suggests that a
pertussis toxin-insensitive Gα subunit compensates in
part for the lack of Gαi2 or that a heterotrimeric G pro-
tein-independent pathway can partially compensate. We
favor the possibility that the loss of Gαi2 allows those βγ
subunits that trigger chemotaxis to become associated
with another Gα subunit to form a heterotrimeric G pro-
tein capable of being activated by chemokine receptors.
Pertussis toxin-insensitive heterotrimeric G protein candi-
dates include Gq subfamily members or perhaps Gz, a Gi
family member insensitive to pertussis toxin. Recently,
the G2A receptor has been reported to trigger macro-
phage chemotaxis by activating a non-Gi heterotrimeric
G protein (Yang et al., 2004). Most assuredly, T cells and
dendritic cells from the Gnai2−/− mice also have defects
in chemokine receptor signaling. The most telling evi-
dence of poor chemokine receptor signaling in vivo is
the defective lymph node and Peyer’s patch develop-
ment in these mice. Normally, CXCR5 and CCR7 signal-
ing promotes the accumulation of CD4+CD3−IL-7Rαhi
cells in sites of future Peyer’s patches and lymph
nodes, where they provide the IL-7Rα-dependent sig-
nals (Luther et al., 2003). In the absence of Gnai2,
CXCR5 and CCR7 signaling is compromised sufficiently
to impair normal lymph node and Peyer’s patch devel-
opment, although mesenteric lymph nodes and an oc-
casional inguinal lymph node can develop. Interest-
ingly, approximately 20% of the Rgs1−/− mice that we
have examined lack popliteal and/or inguinal lymph
nodes, thereby suggesting that excessive signaling
through these receptors may be detrimental.
In summary, Rgs1−/− B cells enter lymph nodes more
efficiently than do wild-type B cells, while the converse
holds for Gnai2−/− B cells. The Rgs1−/− B cells rapidly
enter lymph node follicles and move on average more
quickly than do wild-type B cells, while Gnai2−/− B cells
move more sluggishly. These results indicate that Gi
signaling within the B cell follicle impacts B cell motility
within the follicle. The mechanism by which B cells
leave the follicle remains enigmatic. The motility of the
B cells within the follicles suggests a physical barrier
that restricts their return to the interfollicular region. B
cell activation within the lymph node likely raises RGS1
levels and may promote retention of activated cells. Fi-
nally, the chemokine receptors CCR7, CXCR4, and
CXCR5 on B lymphocytes predominantly couple to Gαi2
and in its absence do not efficiently use Gαi3. The de-
creased signaling through CCR7 and CXCR5 in the
Gnai2−/− mice undoubtedly accounts for their defective
peripheral lymph node and Peyer’s patch development.
Future studies will focus on the role of Rgs1 in lympho-
cyte retention and defining the additional signals that
control B lymphocyte trafficking through lymphoid
organs.
Experimental Procedures
Mice
−/− −/−The generation of Rgs1 mice and Gnai2 mice has been pre-
viously described (Moratz et al., 2004b; Rudolph et al., 1995). Both
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352mutations were backcrossed onto a C57BL/6 background six p
mtimes. C57BL/6 mice were purchased from Jackson Laboratory
(Bar Harbor, ME). All mice used in this study were female and were i
i8–14 weeks of age. Mice were housed under specific pathogen-
free conditions and were used in accordance to the guidelines of i
Ithe Institutional Animal Care Committee at the National Institutes
of Health. (
w
Reagents
HAnti-mouse antibodies against CD11c, Gr-1, CD4, CD8a, and
BCD62L were purchased from BD Pharmingen (San Diego, CA), and
aGαi1, Gαi2, and Gαi3 were purchased from Santa Cruz (Santa Cruz,
iCA). Pertussis toxin was purchased from Calbiochem (La Jolla,
lCA). (5-(and-6)-(((4-chloromethyl)benzoyl)amino)tetramethylrhoda-
dmine) (CMTMR) and 5-chloromethylfluorescein diacetate (CMFDA)
lwere purchased from Molecular Probes (Eugene, OR). Murine
TCCL19, CXCL12, and CXCL13 were purchased from R&D Systems
a(Minneapolis, MN).
f
uCells
aSplenic B cells were isolated by negative depletion by using biotin-
ylated antibodies to CD4, CD8, GR-1, and CDllc (BD PharMingen)
Cand DynabeadsR M-280 Streptavidin (Dynal, Inc., Oslo, Norway) as
Cpreviously described (Moratz et al., 2004b). Purity was typically
amore than 90%. Cells were placed in complete RPMI 1640 medium
msupplemented with 10% FCS, 2 mM L-glutamine, 100 IU/ml penicil-
2lin, 100 µg/ml streptomycin, and 50 M 2-mercaptoethanol.
p
uIntravital Two-Photon Microscopy
wSplenic B cells were labeled for 15 min at 37°C with 2.5–5 M
RCMTMR or CMFDA (Mempel et al., 2004). Subsequently, 7–10 mil-
wlion labeled B cells of each population in 200 l PBS were adop-
mtively transferred by tail vein injection into 6- to 10-week-old recipi-
dent mice. Mice were anaesthetized by an intraperitoneal injection
tof Avertin (tribromoethanol, Sigma, St. Louis, MO) at 300 mg/kg
(Miller et al., 2003). The inguinal lymph node was prepared micro-
Isurgically for intravital microscopy. After shaving, the skin and fatty
Ctissue over the inguinal lymph node were removed. Care was taken
2to spare blood vessels, which were revealed by intravenous injec-
ation of 2% tetramethylrhodamine β-isothiocyanate-dextran (Molec-
tular Probes) in some experiments. The mouse was placed in a pre-
5warmed coverglass chamber (Lab-Tek II, Nalge Nunc International,
wIL). The surrounding tissue was attached to the base of the cham-
fber with veterinary-grade glue (Nexaband, Abbott, IL) to minimize
fthe tissue drift, and 2 ml prewarmed PBS at 37°C was added. The
sdish was then placed into the heating stage adaptor (Harvard Ap-
Pparatus, Holliston, MA) on the microscope. The temperature of
PBS, the tissue near the lymph node, and the surrounding closed
Tair was monitored and maintained at 36.5°C ± 0.5°C. Inguinal lymph
Fnode was intravitally imaged from the capsule (50–100 m deep).
tTwo-photon imaging was performed with an inverted Leica TCS-
bSP2 MP confocal microscope (Leica Microsystems) equipped with
ca 20× multi-immersion objective, 0.7 NA (immersion medium used
c80% glycerol). Two-photon excitation was provided by a Mai Tai
aTi:Sapphire laser (Spectra Physics) with a 10W pump, tuned to 800
pnm. For four-dimensional analysis of cell migration, stacks of five
Rsections (z step = 3 m) were acquired every 15–30 s to provide an
timaging volume of up to 12 m in depth. Emitted fluorescence was
Ccollected by using a two-channel nondescanned detector. Wave-
tlength separation was conducted through a dichroic mirror at 560
anm followed by 525/50 nm and 610/75 nm emission filters. Se-
wquences of image stacks were transformed into volume-rendered
four-dimensional movies by using Imaris software v.4.1.1 (Bitplane,
Switzerland), and the spot analysis was used for semiautomated S
tracking of cell motility in three dimensions by using the param- I
eters of autoregressive motion as an algorithm, 8 m spot diame- v
ter, 2 m background object diameter, and 7 m maximum dis- m
tance (every 15 s). The data set was corrected for tissue drift by (
the Imaris software. M
SIntravital Epifluorecence Microscopy
Intravital microscopy of inguinal lymph node microcirculation was S
pdone as described (von Andrian, 1996; von Andrian and Mem-el,2003). After transferring the mouse to the microscope, 10–20
illion labeled cells of each population were injected intravenously
nto recipient mice. Fluorescence dye-labeled B cells were visual-
zed in the microcirculation by epifluorescence illumination with an
nverted Zeiss Axiovert135 microscope equipped with 20× lens.
mages were recorded every 1–5 s with a Sensicam em camera
The Cooke Co., Auburn Hill, MI). Rolling and sticking fractions
ere calculated as described previously (Warnock et al., 1998).
oming Assay
cells were labeled with 2 M CMFDA and CMTMR for 15 min
t 37°C, and 7–20 million cells of each population were injected
ntravenously into recipient mice. After 2 and 24 hr, spleen, inguinal
ymph nodes, and popliteal lymph nodes were removed and gently
issociated into single-cell suspensions. Peripheral blood was col-
ected by cardiac puncture. After removing red blood cells with
ris-NH4Cl, the cells were resuspended in PBS containing 1% BSA
t 4°C. Flow cytometric analysis was performed on a FACSCalibur
low cytometer (BD Biosciences), and the data were analyzed by
sing the FlowJo software (Tree Star, Inc., San Carlos, CA). Forward
nd side scatter parameters were used to gate on live cells.
hemotaxis
hemotaxis assays were performed by using a transwell chamber
s previously described (Moratz et al., 2004b). In some experi-
ents, B cells were incubated with 1–10 ng/ml pertussis toxin for
hr at 37°C. The cells were washed twice, resuspended in com-
lete RPMI 1640 medium, and added in a volume of 100 µl to the
pper wells of a 24-well transwell plate with a 5 µm insert. Lower
ells contained various doses of chemokines in 600 µl complete
PMI 1640 medium. The number of cells that migrated to the lower
ell following a 2 hr incubation was counted by using a flow cyto-
eter. For checkerboard analysis, cells were resuspended in me-
ium containing various concentrations of CXCL12 just before
ransferring them to the upper chamber.
mmunoblotting
ell lysates were prepared as previously described (Shi et al.,
004). The detergent-insoluble materials were removed, and equal
mounts of protein were fractionated by 10% SDS-PAGE and
ransferred to pure nitrocellulose. Membranes were blocked with
% BSA in Tween 20 plus TBS (TTBS) for 1 hr and then incubated
ith an appropriate dilution of the primary Ab in 5% BSA in TTBS
or 2 hr. The blots were incubated with biotinylated Ab for 1 hr and
urther incubated with streptavidin conjugated to HRP for 1 hr. The
ignal was detected by enhanced chemiluminescence (Amersham
harmacia Biotech, Piscataway, NJ).
hree-Dimensional Collagen Matrix Culture and B Cell Velocity
luorescently dye-labeled wild-type or Rgs1−/− B cells were cul-
ured in three-dimensional collagen matrix as previously described,
ut with minor modifications (Friedl et al., 1995). In brief, 1 × 107 B
ells were suspended in 375 l collagen matrix (1.67 mg/ml type I
ollagen [pH 7.0], Vitrogen). The cell mixture was transferred to
glass-bottom culture dish (MatTek Corporation) and allowed to
olymerize for 1 hr at 37°C. After polymerization, 1 ml complete
PMI 1640 medium was added, and the three-dimensional cell cul-
ures were incubated at 37°C in a humidified atmosphere of 5%
O2. Time-lapse microscopy and computer-assisted single-cell
racking analyzed migration of cells. All images were collected with
20× Plan-Apochromat objective. IPLab 3.6 software (Scanalytics)
as used for image processing.
tatistics
n vivo results represent samples from 3–4 mice per experiment. In
itro results represent mean values of triplicate samples. All experi-
ents were performed more than three times. Standard deviation
SD) and p values were calculated with a Student’s t test by using
icrosoft Excel software.
upplemental Data
upplemental Data including three movies from the intravital two-
hoton microscopy, one movie from the intravital epifluorecence
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353microscopy, one figure that compares the migratory paths of dif-
ferent B cells in the lymph node follicle, one figure showing ERK
activation following chemokine stimulation of Gnai2−/− and wild-
type B cells, and one table that shows the expression profiles of
the adhesion molecules present on the B cells from the different
mice are available at http://www.immunity.com/cgi/content/full/22/
3/343/DC1/.
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